Average Co-Inventor Count = 5.46
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novo Nordisk A/s (16 from 1,777 patents)
16 patents:
1. 12152063 - Insulin analogues and uses thereof
2. 12122818 - Insulin analogues and uses thereof
3. 12098400 - Highly potent ISVD compounds capable of substituting for FVIII(A)
4. 11498951 - Insulin analogues and uses thereof
5. 11208452 - Insulins with polar recombinant extensions
6. 11167035 - Insulin compositions and method of making a composition
7. 9512195 - Insulin derivatives containing additional disulfide bonds
8. 9260502 - Protease-stabilized insulin analogues
9. 9187547 - Human insulin analogues and derivatives comprising cysteine substitutions
10. 9040660 - Long-acting gastrin derivatives
11. 9034818 - Pharmaceutical formulations comprising an insulin derivative
12. 9018161 - Protease resistant insulin analogues
13. 8933021 - Insulin derivative
14. 8883722 - Human insulin containing additional disulfide bonds
15. 8853155 - Insulin derivatives containing additional disulfide bonds